Patent Assignment
Reel/Frame 059742/0836
Merger and Change of Name
Recorded: 2022-04-27
Pages: 5
Assignors
LUMENA PHARMACEUTICALS LLC
Executed: 2020-06-26
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2020-06-26
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 27, 2022
From: GEDULIN, BRONISLAVA; GREY, MICHAEL; O'DONNELL, NIALL
To: LUMENA PHARMACEUTICALS, INC.
Reel/Frame 059740/0996 →
Change of Address
Apr 27, 2022
From: LUMENA PHARMACEUTICAL LLC
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 059808/0186 →
Change of Name
Apr 27, 2022
From: LUMENA PHARMACEUTICALS, INC.
To: LUMENA PHARMACEUTICAL LLC
Reel/Frame 059809/0491 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 59809 Frame 491. Assignor(S) Hereby Confirms the Change of Name.
Apr 15, 2025
From: LUMENA PHARMACEUTICALS, INC.
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 070849/0951 →
Corrective Assignment to Correct the Conveying Party Data and Receiving Party Address Previously Recorded on Reel 59808 Frame 186. Assignor(S) Hereby Confirms the Change of Address.
Apr 15, 2025
From: LUMENA PHARMACEUTICALS LLC
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 071079/0597 →